Melinta Therapeutics to Participate in Two Upcoming Investor Conferences
NEW HAVEN, Conn., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held commercial-stage company developing novel antibiotics to treat serious bacterial infections, announced that it will be presenting at the following upcoming investor …